|
Risk factor
|
Without age–gender interaction term
|
With age–gender interaction term
|
|---|
|
aORa
|
95% CI
|
P
|
aORb
|
95% CI
|
P
|
|---|
|
Individual risk factors
|
|
Age group (years)
| | | | | | |
|
0–14
|
2.66
|
1.08–6.62
|
0.035
|
4.80
|
1.40–16.42
|
0.015
|
|
15–29
|
1.83
|
0.91–3.70
|
0.089
|
3.78
|
1.23–11.66
|
0.023
|
|
30–44 (ref)
|
1.00
| | |
1.00
| | |
|
45–59
|
1.28
|
0.64–2.55
|
0.476
|
3.37
|
1.0–10.32
|
0.035
|
|
60+
|
4.03
|
1.53–10.59
|
0.007
|
12.82
|
3.34–49.18
|
0.001
|
|
Male gender
|
1.88
|
1.10–3.23
|
0.024
|
6.89
|
2.13–22.28
|
0.002
|
|
Age-gender (male) interaction
| | | | | | |
|
0–14
| | | |
0.38
|
0.07–2.10
|
0.253
|
|
15–29
| | | |
0.29
|
0.07–1.16
|
0.078
|
|
30–44 (ref)
| | | |
1.00
| | |
|
45–59
| | | |
0.17
|
0.04–0.68
|
0.015
|
|
60+
| | | |
0.10
|
0.02–0.45
|
0.004
|
|
Moved to current village of residence
|
2.57
|
1.08–6.15
|
0.035
|
2.62
|
1.12–6.11
|
0.027
|
|
Ever declined MDA medication
|
10.52
|
3.86–28.72
|
< 0.001
|
11.82
|
4.25–32.91
|
< 0.001
|
|
Household risk factors
|
|
Township
| | | | | | |
|
Amarapura
|
2.41
|
1.14–5.12
|
0.024
|
2.48
|
1.15–5.31
|
0.022
|
|
Patheingyi
|
2.07
|
0.69–6.17
|
0.183
|
1.89
|
0.63–5.68
|
0.246
|
|
Tada-U
|
0.55
|
0.24–1.23
|
0.136
|
0.55
|
0.24–1.26
|
0.149
|
|
Wundwin (ref)
|
1.00
| | |
1.00
| | |
|
Total number of MDA programme visits (by n of 6)
|
0.67
|
0.46–0.97
|
0.033
|
0.69
|
0.48–1.00
|
0.047
|
|
Proportion of household present during last MDA (by ratio)
|
0.17
|
0.04–0.80
|
0.026
|
0.16
|
0.03–0.74
|
0.021
|
- aAdjusted for survey design
- b95% confidence interval
- Italics values indicate P < 0.05
